CORC

浏览/检索结果: 共133条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Treatment duration as a surrogate endpoint to evaluate the efficacy of crizotinib in sequential therapy for patients with advanced ALK-positive non-small cell lung cancer: A retrospective, real-world study 期刊论文
2019, 卷号: 8, 期号: 13, 页码: 5823-5830
作者:  Yang Guangjian;  Ma Di;  Xu Haiyan;  Yang Lu;  Li Junling
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
REAL WORLD TREATMENT PATTERNS ANALYSIS FOR PATIENTS WITH ADVANCED OR METASTATIC LUNG CANCER IN THEIR INITIAL TREATMENT: A NATIONWIDE, MULTI-CENTER, RETROSPECTIVE MEDICAL CHART REVIEW IN CHINA (PASSION STUDY) 期刊论文
2019, 卷号: 22, 页码: S95-S95
作者:  Qiu, B.;  Fan, L.;  Tang, Z.;  He, J.;  Wang, P. F.
收藏  |  浏览/下载:7/0  |  提交时间:2020/01/03
Apatinib as non -first -line treatment in patients with advanced cholangiocarcinoma 期刊论文
2019, 卷号: 30
作者:  Lin, J.;  Yang, X.;  Mao, J.;  Wang, D.;  Zhang, L.
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Correction to: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 50
作者:  Liao Jun-Fang;  Zhang Qun;  Du Xiao-Jing;  Lan Mei;  Liu Shan
收藏  |  浏览/下载:25/0  |  提交时间:2020/01/03
Apatinib as non -first -line treatment in patients with advanced cholangiocarcinoma 会议论文
ANNALS OF ONCOLOGY, 2019-07-01
作者:  Lin, J.;  Yang, X.;  Mao, J.;  Wang, D.;  Zhang, L.
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03
China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy 期刊论文
2019, 卷号: 39, 期号: 1, 页码: 36
作者:  Zhou, Ming;  Chen, Xiaoyuan;  Zhang, Hong;  Xia, Lin;  Tong, Xin
收藏  |  浏览/下载:29/0  |  提交时间:2020/01/03
Sequential therapy according to distinct disease progression patterns in advanced ALK-positive non-small-cell lung cancer after crizotinib treatment 期刊论文
2019, 卷号: 31, 期号: 2, 页码: 349-356
作者:  Xu, Haiyan;  Ma, Di;  Yang, Guangjian;  Li, Junling;  Hao, Xuezhi
收藏  |  浏览/下载:10/0  |  提交时间:2020/01/03
Clinical Modality of Resistance and Subsequent Management of Patients with Advanced Non-small Cell Lung Cancer Failing Treatment with Osimertinib 期刊论文
2019, 卷号: 14, 期号: 3, 页码: 335-342
作者:  Mu, Yuxin;  Hao, Xuezhi;  Yang, Ke;  Ma, Di;  Wang, Shouzheng
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03
Apatinib combined with chemotherapy in patients with previously treated advanced breast cancer: An observational study 期刊论文
2019, 卷号: 17, 期号: 6, 页码: 4768-4778
作者:  Zhu, Anjie;  Yuan, Peng;  Wang, Jiayu;  Fan, Ying;  Luo, Yang
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03
Radiofrequency deep hyperthermia combined with chemotherapy in the treatment of advanced non-small cell lung cancer 期刊论文
2019, 卷号: 132, 期号: 8, 页码: 922-927
作者:  Yang, Wen-Hui;  Xie, Jun;  Lai, Zhi-Yong;  Yang, Mu-Dan;  Zhang, Ge-Hong
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03


©版权所有 ©2017 CSpace - Powered by CSpace